BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10581224)

  • 21. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases.
    Ghebremedhin E; Rosenberger A; Rüb U; Vuksic M; Berhe T; Bickeböller H; de Vos RA; Thal DR; Deller T
    J Neuropathol Exp Neurol; 2010 May; 69(5):442-8. PubMed ID: 20418782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.
    Perry RH; Irving D; Blessed G; Fairbairn A; Perry EK
    J Neurol Sci; 1990 Feb; 95(2):119-39. PubMed ID: 2157823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease.
    Ho GJ; Hansen LA; Alford MF; Foster K; Salmon DP; Galasko D; Thal LJ; Masliah E
    Neuroreport; 2002 Oct; 13(14):1825-8. PubMed ID: 12395133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
    Brenowitz WD; Keene CD; Hawes SE; Hubbard RA; Longstreth WT; Woltjer RL; Crane PK; Larson EB; Kukull WA
    Neurobiol Aging; 2017 May; 53():83-92. PubMed ID: 28236716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dementia from Alzheimer disease and mixed pathologies in the oldest old.
    James BD; Bennett DA; Boyle PA; Leurgans S; Schneider JA
    JAMA; 2012 May; 307(17):1798-800. PubMed ID: 22550192
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological markers associated with normal aging and dementia in the elderly.
    Crystal HA; Dickson DW; Sliwinski MJ; Lipton RB; Grober E; Marks-Nelson H; Antis P
    Ann Neurol; 1993 Oct; 34(4):566-73. PubMed ID: 8215244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of common neuropathologies on progression of late life cognitive impairment.
    Yu L; Boyle PA; Leurgans S; Schneider JA; Kryscio RJ; Wilson RS; Bennett DA
    Neurobiol Aging; 2015 Jul; 36(7):2225-2231. PubMed ID: 25976345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.
    Jellinger KA
    Neurodegener Dis; 2010; 7(1-3):112-5. PubMed ID: 20173339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.
    Barber R; Scheltens P; Gholkar A; Ballard C; McKeith I; Ince P; Perry R; O'Brien J
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):66-72. PubMed ID: 10369824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
    Davis DG; Schmitt FA; Wekstein DR; Markesbery WR
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):376-88. PubMed ID: 10218633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.
    Honig LS; Kukull W; Mayeux R
    Neurology; 2005 Feb; 64(3):494-500. PubMed ID: 15699381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of cognitive decline in Alzheimer's disease and dementia with Lewy bodies.
    Helmes E; Bowler JV; Merskey H; Munoz DG; Hachinski VC
    Dement Geriatr Cogn Disord; 2003; 15(2):67-71. PubMed ID: 12566594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions.
    Kenny RA; Shaw FE; O'Brien JT; Scheltens PH; Kalaria R; Ballard C
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):966-71. PubMed ID: 15201351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.
    Royall DR; Palmer RF
    Alzheimers Dement; 2013 May; 9(3):318-25. PubMed ID: 23154050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.